Rx Only

Ready for 24-48h Central Dispatch

In Stock

SUBCLAV-375 Clinical Monograph & Batch COA

Certified DCGI Formulation Literature (PDF)

Download

TabletPrescription Required (Schedule Drug)

SUBCLAV-375

Name: SUBCLAV-375
Brand: Sygnus Biotech

Active Drug Composition

Amoxycillin 250mg + Clavulanic Acid 125mg

WHO-GMP Certified Batch ManufacturingDCGI Approved Formulation100% BioavailableAlu-Alu Packaging

SUBCLAV-375 (Amoxycillin 250mg + Clavulanic Acid 125mg) is manufactured under strict WHO-GMP compliance for maximum bioavailability and therapeutic efficacy.

Dosage FormCoated / Uncoated Tablet

Packaging Presentation10 x 10 Alu-Alu / Blister Pack

B2B Distributor & Healthcare Professional Notice:This product is supplied solely through verified licensed pharmaceutical distributors, stockists, and institutional tenders. Online retail checkout for prescription formulations is legally restricted.

Clinical Pharmacology & Therapeutic Profile

Comprehensive therapeutic guidelines for medical practitioners and institutional procurement

Therapeutic Indications

Indicated for therapeutic management within specified clinical indications under qualified physician guidance.

Mechanism of Action (MOA)

The active pharmacological principles in SUBCLAV-375 deliver targeted therapeutic action through standardized systemic bioavailability and verified pharmacodynamics.

Dosage & Posology

As directed by the registered medical practitioner. Strictly adhere to full course duration.

Safety & Precautions

Well tolerated under clinical supervision. Contraindicated in patients with hypersensitivity to active ingredients.

Storage Guidelines

Store below 25°C in a dry place. Protect from moisture and direct sunlight.

WHO-GMP Certified Purity

Manufactured in state-of-the-art HVAC controlled cleanrooms with 100% active ingredient bio-potency and analytical batch testing.

Alu-Alu Moisture Barrier

Superior barrier protection against tropical humidity, preventing physical degradation and guaranteeing 24-month stability.

Exclusive District Monopoly

Strict PCD franchise monopoly allocation ensuring zero price competition and complete territory protection for our partners.

Technical Product Specifications

Therapeutic SegmentTablet

Dosage FormCoated / Uncoated Tablet

Packaging Type10 x 10 Alu-Alu / Blister Pack

Regulatory ScheduleSchedule H

Minimum Order Qty100 Units

Country of OriginIndia (Sidhpur Facility)

Quality StandardWHO-GMP & ISO 9001:2015

Batch Analytical COASupplied with Trade Invoice

Active Medical Composition

SUBCLAV-375 features Amoxycillin 250mg + Clavulanic Acid 125mg prepared to high pharmaceutical purity standards.

Therapeutic ClassificationTablet

Regulatory ScheduleSchedule Drug (Prescription Only)

*Disclaimer: Formulations are intended solely for distribution to licensed practitioners, hospitals, and pharmacies. Dosage must adhere to medical advice.

Monopoly PCD Franchise

Apply for Exclusive Marketing Rights of SUBCLAV-375

Check vacant territory availability in your state or district. Enjoy full marketing kit support, visual aids, and guaranteed zero competitor supply.

Distributor Inquiries

Questions Regarding SUBCLAV-375

What is the therapeutic indication and composition of SUBCLAV-375?

SUBCLAV-375 contains Amoxycillin 250mg + Clavulanic Acid 125mg indicated for Indicated for therapeutic management within specified clinical indications under qualified physician guidance. as formulated by Sygnus Biotech.

What packaging presentations are available for SUBCLAV-375?

SUBCLAV-375 is supplied in tamper-evident 10 x 10 Alu-Alu / Blister Pack, engineered with barrier foil protection to ensure a 24 to 36 month shelf life.

Is monopoly PCD franchise territory available for SUBCLAV-375?

Yes, Sygnus Biotech grants exclusive district-wise monopoly marketing rights for SUBCLAV-375 along with promotional visual aids, product cards, and marketing support.